Xiao NJ, Chu JG, Ning SB, Wei BJ, Xia ZB, Han ZY. Successful management of bleeding ectopic small bowel varices secondary to portal hypertension: A retrospective study. World J Gastrointest Surg 2025; 17(3): 102589 [DOI: 10.4240/wjgs.v17.i3.102589]
Corresponding Author of This Article
Zhe-Yi Han, Department of Gastroenterology, Air Force Medical Center, Air Force Medical University, No. 30 Fucheng Road, Haidian District, Beijing 100142, China. zheyihan_fmmu@163.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Nian-Jun Xiao, Jian-Guo Chu, Shou-Bin Ning, Bao-Jie Wei, Zhi-Bo Xia, Zhe-Yi Han, Department of Gastroenterology, Air Force Medical Center, Air Force Medical University, Beijing 100142, China
Author contributions: Xiao NJ contributed to manuscript writing; Xiao NJ and Han ZY contributed to manuscript revision and data collection; Xiao NJ, Chu JG, Wei BJ, and Xia ZB contributed to the interventional radiology; Xiao NJ and Ning SB contributed to the enteroscopic injection sclerotherapy; and all authors have read and approved the final manuscript.
Supported by the Air Force Medical Center Outstanding Youth Program, No. 2022YXQNNO36.
Institutional review board statement: This study was approved by the Medical Ethics Committee of Air Force Medical Center, Air Force Medical University (approval No. 2023-151-S01).
Informed consent statement: All study participants have provided informed written consent before study enrollment.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: No additional data are available.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zhe-Yi Han, Department of Gastroenterology, Air Force Medical Center, Air Force Medical University, No. 30 Fucheng Road, Haidian District, Beijing 100142, China. zheyihan_fmmu@163.com
Received: October 23, 2024 Revised: January 6, 2025 Accepted: January 20, 2025 Published online: March 27, 2025 Processing time: 124 Days and 17.2 Hours
Core Tip
Core Tip: Bleeding ectopic varices located in the small bowel (BEV-SB) caused by portal hypertension is a rare, life-threatening clinical scenario. This retrospective study presented the treatment experience using enteroscopic injection sclerotherapy (EIS) and subsequent interventional radiology (IR) for BEV-SB. From January 2019 to December 2023, 4 of 519 patients with portal hypertension were identified as having BEV-SB. The management duration of phases from the first episode of BEV-SB to the first EIS, from the first EIS to the first IR, and from the first IR to December 2023 were 20 person-months, 42 person-months, and 77 person-months, respectively. The corresponding transfusions at each phase were 34 units, 31 units, and 3.5 units of red blood cells and 13 units, 14 units, and 1 unit of plasma, respectively. After the comprehensive management, no further gastrointestinal bleeding was observed. We conclude that EIS may be effective in achieving hemostasis in BEV-SB, although rebleeding is common, and IR aiming to reduce portal venous pressure may lower the rebleeding rate.
